Individual patient data meta-analysis of continuous diagnostic markers
|
|
- Giles Preston
- 8 years ago
- Views:
Transcription
1 Individual patient data meta-analysis of continuous diagnostic markers J.B. Reitsma Julius Center for Health Sciences and Primary Care UMC Utrecht /
2 Outline IPD benefits Meta-analytical challenges ROC regression based on standardized marker values of cases Example study: mesothelin for diagnosing pleural mesothelioma
3 What is IPD? Traditional meta-analysis uses published summary (aggregate) data from primary studies Dataset: one row per included study with effect measure(s), their precision and study features Individual Patient Data meta-analysis combines the original (raw, crude) data from individual patients of different studies Dataset: each row is a individual patient with outcomes, patient and study characteristics
4 IPD benefits: general & diagnostic General IPD benefits: quality control & use of additional data & improve comparability Examining patient-level subgroups: more flexibility & more statistical power Continuous marker: handling of differences in cutoffs & better estimation of the summary ROC curve Statistical approach not straightforward
5 IPD Challenges Need to adjust for study when combining curves: Example overall shift in marker values Covariate adjusted ROC curve = weighted average of the study-specific curves Covariates affecting the ROC curve: Covariates have an impact on the overall accuracy: affect the separation between cases and controls) Covariate-specific ROC curves
6 Meta-analytical Challenges
7 ROC curves: need for adjustment Distribution of marker values of control groups differs between studies Mesothelin example: different kits by different studies
8
9 2 ROC curves: Covariate-specific (red) + Pooled ROC curve (black) Prevalence or P(D=1 Z=0) is 25% Prevalence or P(D=1 Z=1) is 75%
10 2 ROC curves: Covariate-specific (red) + Pooled ROC curve (black) Prevalence in Z=0 is 50% Prevalence in Z=1 is 50%
11 Cumulative distribution of Standardized Marker Approach
12 Standardized case marker approach Based on the approach of Janes & Pepe to adjust ROC curves for covariates in a single study Modified steps of their approach: 1. Estimate the cumulative distribution of the marker among controls as a function of study 2. Calculate the percentile values of the cases based on this distribution conditional on study 3. The cumulative distribution of these percentile values of cases is then the weighted ROC curve Janes & Pepe. Adjusting for covariates in studies of diagnostic, screening, or prognostic markers: an old concept in a new setting. Am J Epidmiol 2008.
13 Step 1 & 2: Percentile values of cases based on control distribution Specify how study (Z) affects the distribution of Y among controls: = β + β Z + ε Y 0 1 Calculate percentile values of cases using the control distribution standardized on Z as reference: pv DZ = Fˆ ( Y ( ˆ β + β 0 1Z )) Interpretation percentile values (pv): If a case has value Y and 20% of the corresponding controls have a value higher than Y, the pv =0.2 Also known as placement value
14 Calculate ROC curve using PV of cases ROC curve is the cumulative pv distribution of cases: ROC( f ) = P(1 pv f DZ ) To fit ROC, select a set (p) of discrete False Positive Rate values (f) spanning the interval (0,1) For each case create, n p records where the outcome is either U=1 or 0 A binary regression model with link g, outcome U and covariate g -1 (f) will generate the binormal (g=standard normal CDF) or bilogistic ROC curve Bootstrap to obtain standard errors or CI bands
15 Case Study: Mesothelin for Mesothelioma
16 Mesothelin for malignant mesothelioma Mesothelioma is asbestos-related malignancy with a poor prognosis in general Early diagnosis improves outcome, but diagnosis typically occurs in advanced stage due to non-specific complaints & slow onset Biomarkers may lead to an earlier diagnosis Problems identified in traditional reviews: - use of different cut-offs - non-standardized measurements - impact clinical subgroups Hollevoet et al. J Clin Oncol 2012
17 Hollevoet et al. Journal of Clinical Oncology 2012
18 Mesothelin example Hollevoet et al. J Clin Oncol 2012
19 Mesothelin example
20 Mesothelin example AUC = average of percentile values of cases Hollevoet et al. J Clin Oncol 2012
21 Discussion & Conclusion IPD data generate much more insight in the distribution of marker values across studies Better estimation of summary ROC curve and comparison of ROC curves between subgroups IPD no cure for poorly designed studies Approach of placement values appears attractive: flexible and use of existing techniques Comparison with alternative approaches needed
Knowledge Discovery and Data Mining
Knowledge Discovery and Data Mining Lecture 15 - ROC, AUC & Lift Tom Kelsey School of Computer Science University of St Andrews http://tom.home.cs.st-andrews.ac.uk twk@st-andrews.ac.uk Tom Kelsey ID5059-17-AUC
More informationBiomarker Discovery and Data Visualization Tool for Ovarian Cancer Screening
, pp.169-178 http://dx.doi.org/10.14257/ijbsbt.2014.6.2.17 Biomarker Discovery and Data Visualization Tool for Ovarian Cancer Screening Ki-Seok Cheong 2,3, Hye-Jeong Song 1,3, Chan-Young Park 1,3, Jong-Dae
More informationMethods for Meta-analysis in Medical Research
Methods for Meta-analysis in Medical Research Alex J. Sutton University of Leicester, UK Keith R. Abrams University of Leicester, UK David R. Jones University of Leicester, UK Trevor A. Sheldon University
More informationStrategies for Identifying Students at Risk for USMLE Step 1 Failure
Vol. 42, No. 2 105 Medical Student Education Strategies for Identifying Students at Risk for USMLE Step 1 Failure Jira Coumarbatch, MD; Leah Robinson, EdS; Ronald Thomas, PhD; Patrick D. Bridge, PhD Background
More informationEvaluation of Diagnostic Tests
Biostatistics for Health Care Researchers: A Short Course Evaluation of Diagnostic Tests Presented ed by: Siu L. Hui, Ph.D. Department of Medicine, Division of Biostatistics Indiana University School of
More informationDespite its emphasis on credit-scoring/rating model validation,
RETAIL RISK MANAGEMENT Empirical Validation of Retail Always a good idea, development of a systematic, enterprise-wide method to continuously validate credit-scoring/rating models nonetheless received
More informationTHE RISK DISTRIBUTION CURVE AND ITS DERIVATIVES. Ralph Stern Cardiovascular Medicine University of Michigan Ann Arbor, Michigan. stern@umich.
THE RISK DISTRIBUTION CURVE AND ITS DERIVATIVES Ralph Stern Cardiovascular Medicine University of Michigan Ann Arbor, Michigan stern@umich.edu ABSTRACT Risk stratification is most directly and informatively
More informationOrganizing Your Approach to a Data Analysis
Biost/Stat 578 B: Data Analysis Emerson, September 29, 2003 Handout #1 Organizing Your Approach to a Data Analysis The general theme should be to maximize thinking about the data analysis and to minimize
More informationOriginal Article Performance of osteopontin in the diagnosis of malignant pleural mesothelioma: a meta-analysis
Int J Clin Exp Med 2014;7(5):1289-1296 www.ijcem.com /ISSN:1940-5901/IJCEM0000365 Original Article Performance of osteopontin in the diagnosis of malignant pleural mesothelioma: a meta-analysis Hui Lin
More informationMeasures of diagnostic accuracy: basic definitions
Measures of diagnostic accuracy: basic definitions Ana-Maria Šimundić Department of Molecular Diagnostics University Department of Chemistry, Sestre milosrdnice University Hospital, Zagreb, Croatia E-mail
More informationNon-invasive diagnosis of pleural malignancies: The role of tumour markers
Lung Cancer (2008) 59, 350 354 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/lungcan Non-invasive diagnosis of pleural malignancies: The role of tumour markers Michel M.
More informationData Mining Techniques for Prognosis in Pancreatic Cancer
Data Mining Techniques for Prognosis in Pancreatic Cancer by Stuart Floyd A Thesis Submitted to the Faculty of the WORCESTER POLYTECHNIC INSTITUE In partial fulfillment of the requirements for the Degree
More informationCombined CA125 and Mesothelin Levels for the Diagnosis of Malignant Mesothelioma*
CHEST Combined CA125 and Mesothelin Levels for the Diagnosis of Malignant Mesothelioma* Jenette Creaney, PhD; Ivonne van Bruggen, BSc; Michelle Hof, BSc; Amanda Segal, MBBS; Arthur W. Musk, MBBS, MD, FCCP;
More informationUpdate on Mesothelioma
November 8, 2012 Update on Mesothelioma Intro incidence and nomenclature Update on Classification Diagnostic specimens Morphologic features Epithelioid Histology Biphasic Histology Immunohistochemical
More informationSTATISTICA Formula Guide: Logistic Regression. Table of Contents
: Table of Contents... 1 Overview of Model... 1 Dispersion... 2 Parameterization... 3 Sigma-Restricted Model... 3 Overparameterized Model... 4 Reference Coding... 4 Model Summary (Summary Tab)... 5 Summary
More informationCredit Risk Models. August 24 26, 2010
Credit Risk Models August 24 26, 2010 AGENDA 1 st Case Study : Credit Rating Model Borrowers and Factoring (Accounts Receivable Financing) pages 3 10 2 nd Case Study : Credit Scoring Model Automobile Leasing
More informationSOME STATISTICAL ISSUES IN THE DESIGN AND ANALYSIS OF VACCINE CLINICAL TRIALS IN CANCER PATIENTS
SOME STATISTICAL ISSUES IN THE DESIGN AND ANALYSIS OF VACCINE CLINICAL TRIALS IN CANCER PATIENTS isbtc Workshop; 10/28/09 DOUGLAS M. POTTER Biostatistics Department, Graduate School of Public Health, University
More informationScatter Plots with Error Bars
Chapter 165 Scatter Plots with Error Bars Introduction The procedure extends the capability of the basic scatter plot by allowing you to plot the variability in Y and X corresponding to each point. Each
More informationRESEARCH ARTICLE. Fibulin-3 as a Diagnostic Biomarker in Patients with Malignant Mesothelioma
DOI:http://dx.doi.org/10.7314/APJCP.2015.16.4.1403 RESEARCH ARTICLE Fibulin-3 as a Diagnostic Biomarker in Patients with Malignant Mesothelioma Halide Kaya 1 *, Melike Demir 1, Mahsuk Taylan 1, Cengizhan
More informationHealth Care and Life Sciences
Sensitivity, Specificity, Accuracy, Associated Confidence Interval and ROC Analysis with Practical SAS Implementations Wen Zhu 1, Nancy Zeng 2, Ning Wang 2 1 K&L consulting services, Inc, Fort Washington,
More informationL Lang-Lazdunski, A Bille, S Marshall, R Lal, D Landau, J Spicer
Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine and systemic chemotherapy in malignant pleural mesothelioma. A 10-year experience. L Lang-Lazdunski, A Bille, S Marshall, R Lal,
More informationJournal of Information
Journal of Information journal homepage: http://www.pakinsight.com/?ic=journal&journal=104 PREDICT SURVIVAL OF PATIENTS WITH LUNG CANCER USING AN ENSEMBLE FEATURE SELECTION ALGORITHM AND CLASSIFICATION
More informationDIAPHRAGM. DIAgnostic and Prognostic biomarkers in the Rational Assessment of Mesothelioma
DIAPHRAGM DIAgnostic and Prognostic biomarkers in the Rational Assessment of Mesothelioma Kevin Blyth Consultant Respiratory Physician, Southern General Hospital NRS Research Fellow & Honorary Clinical
More informationRulex s Logic Learning Machines successfully meet biomedical challenges.
Rulex s Logic Learning Machines successfully meet biomedical challenges. Rulex is a predictive analytics platform able to manage and to analyze big amounts of heterogeneous data. With Rulex, it is possible,
More informationSystematic Reviews and Meta-analyses
Systematic Reviews and Meta-analyses Introduction A systematic review (also called an overview) attempts to summarize the scientific evidence related to treatment, causation, diagnosis, or prognosis of
More informationABSTRACT INTRODUCTION
Paper SP03-2009 Illustrative Logistic Regression Examples using PROC LOGISTIC: New Features in SAS/STAT 9.2 Robert G. Downer, Grand Valley State University, Allendale, MI Patrick J. Richardson, Van Andel
More informationBayesian Penalized Methods for High Dimensional Data
Bayesian Penalized Methods for High Dimensional Data Joseph G. Ibrahim Joint with Hongtu Zhu and Zakaria Khondker What is Covered? Motivation GLRR: Bayesian Generalized Low Rank Regression L2R2: Bayesian
More informationS03-2008 The Difference Between Predictive Modeling and Regression Patricia B. Cerrito, University of Louisville, Louisville, KY
S03-2008 The Difference Between Predictive Modeling and Regression Patricia B. Cerrito, University of Louisville, Louisville, KY ABSTRACT Predictive modeling includes regression, both logistic and linear,
More informationRare Thoracic Tumours
Rare Thoracic Tumours 1. Epithelial Tumour of Trachea 1 1.1 General Results Table 1. Epithelial Tumours of Trachea: Incidence, Trends, Survival Flemish Region 2001-2010 Both Sexes Incidence Trend EAPC
More informationThe interpretation of diagnostic tests
Statistical Methods in Medical Research 1999; 8: 113±134 The interpretation of diagnostic tests David E Shapiro Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts,
More informationChapter 4 - Lecture 1 Probability Density Functions and Cumul. Distribution Functions
Chapter 4 - Lecture 1 Probability Density Functions and Cumulative Distribution Functions October 21st, 2009 Review Probability distribution function Useful results Relationship between the pdf and the
More informationNHS Diabetes Prevention Programme (NHS DPP) Non-diabetic hyperglycaemia. Produced by: National Cardiovascular Intelligence Network (NCVIN)
NHS Diabetes Prevention Programme (NHS DPP) Non-diabetic hyperglycaemia Produced by: National Cardiovascular Intelligence Network (NCVIN) Date: August 2015 About Public Health England Public Health England
More informationMalignant Pleural Diseases Advances Clinicians Should Know F Gleeson
Malignant Pleural Diseases Advances Clinicians Should Know F Gleeson The following relevant disclosures, conflicts of interest and/ or financial relationships exist related to this presentation: Consultant
More informationBeware that Low Urine Creatinine! by Vera F. Dolan MSPH FALU, Michael Fulks MD, Robert L. Stout PhD
1 Beware that Low Urine Creatinine! by Vera F. Dolan MSPH FALU, Michael Fulks MD, Robert L. Stout PhD Executive Summary: The presence of low urine creatinine at insurance testing is associated with increased
More informationBig Data and Oncology Care Quality Improvement in the United States
Big Data and Oncology Care Quality Improvement in the United States Peter P. Yu, MD, FACP, FASCO President, American Society of Clinical Oncology Director of Cancer Research, Palo Alto Medical Foundation
More informationMedicalBiostatistics.com
1 MedicalBiostatistics.com HOME ROC Curve Many full term births in a hospital require induction of labor. Induction succeeds in most cases but fails in a few. In case the induction fails, a Cesarean is
More informationOccupational respiratory diseases due to Asbestos. Dirk Dahmann, IGF, Bochum
Occupational respiratory diseases due to Asbestos Dirk Dahmann, IGF, Bochum Contents Introduction Diseases Further Effects Preventive Strategies Conclusion Asbestos minerals Woitowitz, 2003 Imports (+
More informationEarly Detection Research Network: Validation Infrastructure. Jo Ann Rinaudo, Ph.D. Division of Cancer Prevention
Early Detection Research Network: Validation Infrastructure Jo Ann Rinaudo, Ph.D. Division of Cancer Prevention 15 October 2015 Mission The NCI Early Detection Research Network s (EDRN) mission is to implement
More informationData Mining. Nonlinear Classification
Data Mining Unit # 6 Sajjad Haider Fall 2014 1 Nonlinear Classification Classes may not be separable by a linear boundary Suppose we randomly generate a data set as follows: X has range between 0 to 15
More informationIdentifying SPAM with Predictive Models
Identifying SPAM with Predictive Models Dan Steinberg and Mikhaylo Golovnya Salford Systems 1 Introduction The ECML-PKDD 2006 Discovery Challenge posed a topical problem for predictive modelers: how to
More informationNational Coverage Determination (NCD) for Tumor Antigen by Immunoassay - CA 125 (190.28)
National Coverage Determination (NCD) for Tumor Antigen by Immunoassay - CA 125 (190.28) Tracking Information Publication Number Manual Section Number 100-3 190.28 Manual Section Title Tumor Antigen by
More information7. Prostate cancer in PSA relapse
7. Prostate cancer in PSA relapse A patient with prostate cancer in PSA relapse is one who, having received a primary treatment with intent to cure, has a raised PSA (prostate-specific antigen) level defined
More informationNa#onal Asbestos Forum 2013: Advance in Medical Research on Asbestos- Related Diseases
Na#onal Asbestos Forum 2013: Advance in Medical Research on Asbestos- Related Diseases Professor Nico van Zandwijk Asbestos Diseases Research Ins#tute Content List of Asbestos- Related Diseases Epidemiology
More informationRetrospective analysis of large scale research screening of construction workers for the early diagnosis of mesothelioma
26 Retrospective analysis of large scale research screening of construction workers for the early diagnosis of mesothelioma TOMOKO HIROHASHI 1, KIYOKO IGARASHI 2, MASAAKI ABE 1, MASAHIRO MAEDA 3 and OKIO
More informationA Bayesian hierarchical surrogate outcome model for multiple sclerosis
A Bayesian hierarchical surrogate outcome model for multiple sclerosis 3 rd Annual ASA New Jersey Chapter / Bayer Statistics Workshop David Ohlssen (Novartis), Luca Pozzi and Heinz Schmidli (Novartis)
More informationR 2 -type Curves for Dynamic Predictions from Joint Longitudinal-Survival Models
Faculty of Health Sciences R 2 -type Curves for Dynamic Predictions from Joint Longitudinal-Survival Models Inference & application to prediction of kidney graft failure Paul Blanche joint work with M-C.
More informationDevelopment and Validation of a Screening Questionnaire for Psoriatic Arthritis
Development and Validation of a Screening Questionnaire for Psoriatic Arthritis Dafna D. Gladman 1, Catherine T. Schentag 1, Brian D. Tom 2, Vinod Chandran 1, Cheryl F. Rosen 1 Vernon T. Farewell 2 1 University
More informationCHILDHOOD CANCER SURVIVOR STUDY Analysis Concept Proposal
CHILDHOOD CANCER SURVIVOR STUDY Analysis Concept Proposal 1. STUDY TITLE: Longitudinal Assessment of Chronic Health Conditions: The Aging of Childhood Cancer Survivors 2. WORKING GROUP AND INVESTIGATORS:
More informationHow can you unlock the value in real-world data? A novel approach to predictive analytics could make the difference.
How can you unlock the value in real-world data? A novel approach to predictive analytics could make the difference. What if you could diagnose patients sooner, start treatment earlier, and prevent symptoms
More informationBayes Theorem & Diagnostic Tests Screening Tests
Bayes heorem & Screening ests Bayes heorem & Diagnostic ests Screening ests Some Questions If you test positive for HIV, what is the probability that you have HIV? If you have a positive mammogram, what
More informationAsbestos-Related Cancer Research and Prevention
Asbestos-Related Cancer Research and Prevention Professor Nico van Zandwijk Asbestos Diseases Research Institute University of Sydney International Conference on Asbestos Awareness and Management 18 November
More informationTitle: A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions. Authors
ERJ Express. Published on July 12, 2012 as doi: 10.1183/09031936.00148211 Title: A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions. Authors 1/. Clare E Hooper clarehooper@doctors.org.uk
More informationAdequacy of Biomath. Models. Empirical Modeling Tools. Bayesian Modeling. Model Uncertainty / Selection
Directions in Statistical Methodology for Multivariable Predictive Modeling Frank E Harrell Jr University of Virginia Seattle WA 19May98 Overview of Modeling Process Model selection Regression shape Diagnostics
More informationPredicting The Risk Of Rheumatoid Arthritis
Predicting The Risk Of Rheumatoid Arthritis Modelling Genetic And Environmental Risk Factors Ian Scott Arthritis Research UK Clinical Research Fellow Declaration Of Interests: No Competing Interests Describe
More informationHow to set the main menu of STATA to default factory settings standards
University of Pretoria Data analysis for evaluation studies Examples in STATA version 11 List of data sets b1.dta (To be created by students in class) fp1.xls (To be provided to students) fp1.txt (To be
More informationSocial inequalities impacts of care management and survival in patients with non-hodgkin lymphomas (ISO-LYMPH)
Session 3 : Epidemiology and public health Social inequalities impacts of care management and survival in patients with non-hodgkin lymphomas (ISO-LYMPH) Le Guyader-Peyrou Sandra Bergonie Institut Context:
More informationCombining diagnostic test results to increase accuracy
Biostatistics (2000),, 2,pp. 23 40 Printed in Great Britain Combining diagnostic test results to increase accuracy MARGARET SULLIVAN PEPE Division of Public Health Sciences, Fred Hutchinson Cancer Research
More informationMedicare Coverage for Individuals Exposed to Asbestos in Lincoln County, Montana. www.socialsecurity.gov/libby
Medicare Coverage for Individuals Exposed to Asbestos in Lincoln County, Montana www.socialsecurity.gov/libby Medicare coverage is available for certain individuals who were exposed to asbestos in Lincoln
More informationPackage ROC632. February 19, 2015
Type Package Package ROC632 February 19, 2015 Title Construction of diagnostic or prognostic scoring system and internal validation of its discriminative capacities based on ROC curve and 0.633+ boostrap
More informationHow To Use An Osteopontin Prognostic Marker In A Cancer
Tropical Journal of Pharmaceutical Research December 2010; 9 (6): 605-613 Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria. All rights reserved. Review Article
More informationScreening for psychological distress in inoperable lung cancer patients: an evaluation of the Brief Distress Thermometer (BDT)
Screening for psychological distress in inoperable lung cancer patients: an evaluation of the Brief Distress Thermometer (BDT) K. Sharkey; A. Ugalde; M. Krishnasamy; K. Gough; D. Ball; S. Aranda; P. Schofield
More informationA Cross-Sectional Study of Asbestos- Related Morbidity and Mortality in Vermonters Residing Near an Asbestos Mine November 3, 2008
A Cross-Sectional Study of Asbestos- Related Morbidity and Mortality in Vermonters Residing Near an Asbestos Mine 108 Cherry Street, PO Box 70 Burlington, VT 05402 802.863.7200 healthvermont.gov A Cross-Sectional
More informationClassification models for predicting a patient clinical status: discussion on the case of the chemotherapy induced neutropenia duration
Classification models for predicting a patient clinical status: discussion on the case of the chemotherapy induced neutropenia duration S. San Matías 1*, M. Clemente 1 and V. Giner Bosch 1 1 Departamento
More informationCGS2 2003 2004 2005 2006 2007 2008 2009 2010 X X X X X
CGS2 Blue, GCS, time Black, GCS, time Red, GCS, time CGS2 Blue, GCS, time Black, GCS, time Red, GCS, time CGS1 Blue, GCS, time Black, GCS, time Red, GCS, time CGS2 (Discontinued) Blue, GCS, time Black,
More informationNon-invasive evaluation of liver fibrosis: current clinical use and next perspectives (chronic hepatitis C)
Non-invasive evaluation of liver fibrosis: current clinical use and next perspectives (chronic hepatitis C) Paul Calès Liver and Gastroenterology department, University hospital & HIFIH laboratory, Angers
More informationThe 4Kscore blood test for risk of aggressive prostate cancer
The 4Kscore blood test for risk of aggressive prostate cancer Prostate cancer tests When to use the 4Kscore Test? Screening Prior to 1 st biopsy Prior to negative previous biopsy Prognosis in Gleason 6
More informationLeveraging electronic health records for predictive modeling of surgical complications. Grant Weller
Leveraging electronic health records for predictive modeling of surgical complications Grant Weller ISCB 2015 Utrecht NL August 26, 2015 Collaborators: David W. Larson, MD; Jenna Lovely, PharmD, RPh; Berton
More informationUnmet Needs for Parkinson s Disease Therapeutics
Unmet Needs for Parkinson s Disease Therapeutics Coalition Against Major Diseases & FDA Workshop October 20, 2014 Caroline M Tanner MD, PhD Director, Parkinson's Disease Research Education and Clinical
More informationResearch Article Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma
Disease Markers, Article ID 43946, 0 pages http://dx.doi.org/0.55/4/43946 Research Article Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma Jenette Creaney,,2 Amanda
More informationRESEARCH COMMUNICATION. HE4 and Mesothelin: Novel Biomarkers of Ovarian Carcinoma in Patients with Pelvic Masses
HE4 and Mesothelin: Novel Biomarkers of Ovarian Carcinoma RESEARCH COMMUNICATION HE4 and Mesothelin: Novel Biomarkers of Ovarian Carcinoma in Patients with Pelvic Masses Hala A Abdel-Azeez 1 *, Hany A
More informationEVALUATION/PRIORITIZATION CRITERIA: C, L, R, S *to meet requirement 1
COMPENDIA TRANSPARENCY TRACKING FORM DATE: MAY 2015 PACKET: 111 DRUG: INDICATION: Vinorelbine Tartrate Malignant pleural mesothelioma COMPENDIA TRANSPARENCY REQUIREMENTS 1 Provide criteria used to evaluate/prioritize
More informationCancer Medicine. Newly established ELISA for N-ERC/mesothelin improves diagnostic accuracy in patients with suspected pleural mesothelioma
Cancer Medicine ORIGINAL RESEARCH Open Access Newly established ELISA for N-ERC/mesothelin improves diagnostic accuracy in patients with suspected pleural mesothelioma Tadashi Sato 1, Yohei Suzuki 1, Takanori
More informationActuarial projections for mesothelioma: an epidemiological perspective Mark Clements, Geoffrey Berry and Jill Shi
Actuarial projections for mesothelioma: an epidemiological perspective Mark Clements, Geoffrey Berry and Jill Shi 27 slides to go Who are we? I am an epidemiologist/biostatistician from the Australian
More informationOnline estimation of the risk of blood contamination
Online estimation of the risk of blood contamination Welling Oei Transfusion Technology Assessment (TTA) Group Julius Center for Health Sciences and Primary Care, UMC Utrecht, The Netherlands IPFA/PEI
More informationFingerprinting the Datacenter: Automated Classification of Performance Crises
Fingerprinting the Datacenter: Automated Classification of Performance Crises Peter Bodík University of California, Berkeley Armando Fox University of California, Berkeley Moises Goldszmidt Microsoft Research
More informationBasic research methods. Basic research methods. Question: BRM.2. Question: BRM.1
BRM.1 The proportion of individuals with a particular disease who die from that condition is called... BRM.2 This study design examines factors that may contribute to a condition by comparing subjects
More informationHologic Selenia Dimensions C-View Software Module. October 24, 2012
Hologic Selenia Dimensions C-View Software Module October 24, 2012 Introduction and Agenda Peter Soltani, Ph.D. Senior VP & GM, Breast Health Hologic, Inc. Agenda Technology Overview Clinical Overview
More informationIndependent Validation of the Prognostic Gene Expression Ratio Test in Formalin Fixed, Paraffin Embedded (FFPE) Mesothelioma Tumor Tissue Specimens
Independent Validation of the Prognostic Gene Expression Ratio Test in Formalin Fixed, Paraffin Embedded (FFPE) Mesothelioma Tumor Tissue Specimens Assunta De Rienzo, Ph.D. 1, Robert W. Cook, Ph.D. 2,
More informationAdvances in Diagnostic and Molecular Testing in Prostate Cancer
Advances in Diagnostic and Molecular Testing in Prostate Cancer Ashley E. Ross MD PhD Assistant Professor Urology, Oncology, Pathology Johns Hopkins School of Medicine September 24, 2015 1 Disclosures
More informationAFFORDABLE CARE ACT AUTHORIZING LEGISLATION
AFFORDABLE CARE ACT AUTHORIZING LEGISLATION SEC. 10323. MEDICARE COVERAGE FOR INDIVIDUALS EXPOSED TO ENVIRONMENTAL HEALTH HAZARDS. (a) In General- Title XVIII of the Social Security Act (42 U.S.C. 1395
More informationHow to Get More Value from Your Survey Data
Technical report How to Get More Value from Your Survey Data Discover four advanced analysis techniques that make survey research more effective Table of contents Introduction..............................................................2
More informationFibulin-3 as a Blood and Effusion Biomarker for Pleural Mesothelioma
original article Fibulin-3 as a Blood and Effusion Biomarker for Pleural Harvey I. Pass, M.D., Stephen M. Levin, M.D., Michael R. Harbut, M.D., Jonathan Melamed, M.D., Luis Chiriboga, Ph.D., Jessica Donington,
More informationFibulin-3 as a Blood and Effusion Biomarker for Pleural Mesothelioma
original article Fibulin-3 as a Blood and Effusion Biomarker for Pleural Harvey I. Pass, M.D., Stephen M. Levin, M.D., Michael R. Harbut, M.D., Jonathan Melamed, M.D., Luis Chiriboga, Ph.D., Jessica Donington,
More informationDeveloping Risk Adjustment Techniques Using the SAS@ System for Assessing Health Care Quality in the lmsystem@
Developing Risk Adjustment Techniques Using the SAS@ System for Assessing Health Care Quality in the lmsystem@ Yanchun Xu, Andrius Kubilius Joint Commission on Accreditation of Healthcare Organizations,
More informationCEA, AFP, CA125, CA153 and CA199 in Malignant Pleural Effusions Predict the Cause
DOI:http://dx.doi.org/10.7314/APJCP.2014.15.1.363 CEA, AFP, CA125, CA153 and CA199 in Malignant Pleural Effusions Predict the Cause RESEARCH ARTICLE CEA, AFP, CA125, CA153 and CA199 in Malignant Pleural
More information1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1
1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY
More informationJ of Evidence Based Med & Hlthcare, pissn- 2349-2562, eissn- 2349-2570/ Vol. 2/Issue 33/Aug. 17, 2015 Page 5063
PERITONEAL MALIGNANT MESOTHELIOMA: A RARE S. R. Dhamotharan 1, S. Shanthi Nirmala 2, F. Celine Foustina Mary 3, M. Arul Raj Kumar 4, R. Vinothprabhu 5 HOW TO CITE THIS ARTICLE: S. R. Dhamotharan, S. Shanthi
More informationThe risks of mesothelioma and lung cancer in relation to relatively lowlevel exposures to different forms of asbestos
WATCH/2008/7 Annex 1 The risks of mesothelioma and lung cancer in relation to relatively lowlevel exposures to different forms of asbestos What statements can reliably be made about risk at different exposure
More informationMesoPDT. Photodynamic Therapy for malignant pleural mesothelioma ONCO-THAI. Image Assisted Laser Therapy for Oncology
MesoPDT Photodynamic Therapy for malignant pleural mesothelioma ONCO-THAI Image Assisted Laser Therapy for Oncology Unité Inserm ONCO-THAI «Image Assisted Laser Therapy for Oncology» Inserm ONCO-THAI "Image
More informationEffect of Risk and Prognosis Factors on Breast Cancer Survival: Study of a Large Dataset with a Long Term Follow-up
Georgia State University ScholarWorks @ Georgia State University Mathematics Theses Department of Mathematics and Statistics 7-28-2012 Effect of Risk and Prognosis Factors on Breast Cancer Survival: Study
More informationPresenter:Zheng-kun Shi Supervisor:Si-yuan Tang Monica Parry
Presenter:Zheng-kun Shi Supervisor:Si-yuan Tang Monica Parry Meet us Zheng-kun Shi, Master candidate, RN Si-yuan Tang, Professor, PhD, Doctoral supervisor, Postdoctoral Supervisor, Dean of Xiang Ya School
More informationThe diagnostic usefulness of tumour markers CEA and CA-125 in pleural effusion
Malaysian J Path01 2002; 24(1) : 53-58 The diagnostic usefulness of tumour markers CEA and CA-125 in pleural effusion Pavai STHANESHWAR MD, Sook-Fan YAP FRCPath, FRCPA and Gita JAYARAM MDPath, MRCPath
More informationAppendix G STATISTICAL METHODS INFECTIOUS METHODS STATISTICAL ROADMAP. Prepared in Support of: CDC/NCEH Cross Sectional Assessment Study.
Appendix G STATISTICAL METHODS INFECTIOUS METHODS STATISTICAL ROADMAP Prepared in Support of: CDC/NCEH Cross Sectional Assessment Study Prepared by: Centers for Disease Control and Prevention National
More informationScreening, early referral and treatment for asbestos related cancer
Screening, early referral and treatment for asbestos related cancer Marc de Perrot, MD, MSc, FRCSC Toronto Mesothelioma Research Program University of Toronto Asbestos related diseases Mesothelioma Lung
More informationCritical Appraisal of Article on Therapy
Critical Appraisal of Article on Therapy What question did the study ask? Guide Are the results Valid 1. Was the assignment of patients to treatments randomized? And was the randomization list concealed?
More informationAn Empirical Evaluation of Guidelines on Prostate-specific Antigen Velocity in Prostate Cancer Detection
DOI: 10.1093/jnci/djr028 ARTICLE JNCI djr028 MA JOURNAL NAME Art. No. CE Code The Author 2011. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
More informationPROTOCOL OF THE RITA DATA QUALITY STUDY
PROTOCOL OF THE RITA DATA QUALITY STUDY INTRODUCTION The RITA project is aimed at estimating the burden of rare malignant tumours in Italy using the population based cancer registries (CRs) data. One of
More informationResearch Article Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma
Disease Markers Volume 2015, Article ID 282145, 5 pages http://dx.doi.org/10.1155/2015/282145 Research Article Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma Emanuela Taioli,
More informationFINDING SUBGROUPS OF ENHANCED TREATMENT EFFECT. Jeremy M G Taylor Jared Foster University of Michigan Steve Ruberg Eli Lilly
FINDING SUBGROUPS OF ENHANCED TREATMENT EFFECT Jeremy M G Taylor Jared Foster University of Michigan Steve Ruberg Eli Lilly 1 1. INTRODUCTION and MOTIVATION 2. PROPOSED METHOD Random Forests Classification
More informationHow To Predict Diabetes In A Cost Bucket
Paper PH10-2012 An Analysis of Diabetes Risk Factors Using Data Mining Approach Akkarapol Sa-ngasoongsong and Jongsawas Chongwatpol Oklahoma State University, Stillwater, OK 74078, USA ABSTRACT Preventing
More information